Biomaterials Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, China, Japan - Size and Forecast 2024-2028

Biomaterials Market Size 2024-2028

The biomaterials market size is valued to increase USD 12.76 billion, at a CAGR of 5.68% from 2023 to 2028. Increasing prevalence of musculoskeletal diseases and disorders will drive the biomaterials market.

Major Market Trends & Insights

• North America dominated the market and accounted for a 42% growth during the forecast period.
• By Type - Metallic segment was valued at USD 14.44 billion in 2022
• By Application - Orthopedic segment accounted for the largest market revenue share in 2022

Market Size & Forecast

• Market Opportunities: USD 49.76 billion
• Market Future Opportunities: USD 12759.40 billion
• CAGR from 2023 to 2028 : 5.68%

Market Summary

• The market witnesses significant growth, driven by the escalating prevalence of musculoskeletal diseases and disorders, leading to an increased number of joint replacement and arthroplasty surgeries. These procedures often necessitate the use of advanced biomaterials to facilitate faster healing and improve patient outcomes. However, the high cost of bioimplants and surgeries poses a considerable challenge to market expansion. 
• This growth can be attributed to the continuous research and development efforts in creating biocompatible materials for various medical applications, including tissue engineering, drug delivery systems, and dental and orthopedic implants. The market's future direction lies in the development of biodegradable materials, nanotechnology, and 3D printing, offering potential solutions to address the cost concerns while maintaining superior functionality.

What will be the Size of the Biomaterials Market during the forecast period?

Get Key Insights on Market Forecast (PDF) Request Free Sample

How is the Biomaterials Market Segmented ?

The biomaterials industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD billion" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

• Type
  • Metallic
  • Ceramic
  • Polymers
  • Natural
• Application
  • Orthopedic
  • Cardiovascular
  • Dental
  • Neurology
  • Others
• Geography
  • North America
    • US
  • Europe
    • Germany
    • UK
  • APAC
    • China
    • Japan
  • Rest of World (ROW)

By Type Insights

The metallic segment is estimated to witness significant growth during the forecast period.

The market encompasses a wide range of materials, including metals, polymers, ceramics, and composites, each with unique properties that cater to various applications in regenerative medicine, tissue engineering, and medical devices. Metallic biomaterials, such as 316L stainless steel, cobalt-chromium alloys, and titanium-based alloys, are valued for their mechanical strength and durability, making them ideal for load-bearing applications in cardiovascular, dental, and orthopedic implants. Biopolymers, like hydrogels, are gaining popularity due to their biocompatibility and bioresorbability, which enable tissue regeneration and reduce the need for secondary surgeries. Composite biomaterials, combining the advantages of multiple materials, offer enhanced properties for specific applications.

Research and development efforts focus on improving biomaterial degradation rates, cost-effectiveness, and long-term stability, as well as enhancing nanostructured biomaterials and biopolymer synthesis. Mechanical properties testing, surface modification, and biomaterial-cell interactions are crucial for ensuring optimal biocompatibility and cellular response. Biomaterial manufacturing scale-up, regulatory compliance, and sterilization techniques are also critical considerations. The market's evolution reflects ongoing efforts to create advanced materials with superior performance metrics, including drug delivery systems, biomaterial toxicity assays, and 3D bioprinting materials. Biomaterial design principles and processing methods continue to advance, driven by the need for biocompatible polymers, improved bioactivity, and increased biomaterial characterization techniques.

Request Free Sample

The Metallic segment was valued at USD 14.44 billion in 2018 and showed a gradual increase during the forecast period.

Request Free Sample

Regional Analysis

North America is estimated to contribute 42% to the growth of the global market during the forecast period.Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

See How Biomaterials Market Demand is Rising in North America Request Free Sample

The market is experiencing significant growth, with North America holding a substantial share due to an increase in biomaterial-driven research, the rising incidence of cancer and cardiovascular diseases, and the presence of supportive public and private agencies. These factors are driving the expansion of the regional market, with the increasing adoption of advanced joint reconstruction devices and enhanced healthcare infrastructure contributing to its rapid growth.

Furthermore, the demand for implantable devices is surging, further fueling market growth in this region. As a professional, it is essential to acknowledge the market's dynamic nature and the various applications that are propelling its progress.

Market Dynamics

Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

The global biomaterials market is advancing rapidly as research focuses on designing materials with improved performance, biocompatibility, and clinical applicability. Core studies on poly lactic-co-glycolic acid properties, polycaprolactone biomaterial degradation kinetics, and gelatin methacryloyl biomaterial applications continue to demonstrate versatility in controlled degradation and drug delivery. Similarly, hydroxyapatite-based biomaterial applications and bioactive glass biomaterial bone regeneration highlight progress in hard tissue repair, while collagen-based biomaterial scaffold design and fibrin-based biomaterial tissue regeneration address structural and biological requirements for soft tissue engineering. Innovations such as chitosan biomaterial drug delivery efficacy, alginate hydrogel properties and applications, and hydrogels for drug delivery mechanism are reshaping targeted therapeutic delivery systems.

Comparative research underscores the measurable influence of design and testing methods. For instance, biomaterial surface functionalization techniques have demonstrated performance improvements in cell adhesion and integration close to 27.1%, while biomaterial mechanical testing standards yielded consistency metrics nearer to 20.4%. These variations illustrate the importance of precise biomaterial characterization using spectroscopy and biomaterial degradation product analysis, both of which provide critical insights into long-term safety and performance.

Key developments also emphasize functionality in complex biological systems. Silk fibroin biomaterial mechanical properties and polyurethane biomaterial mechanical testing are central to achieving mechanical resilience, while nanofibrous scaffold biomaterial design enables structural mimicry of natural tissues. Equally, poly(ethylene glycol) hydrogel biocompatibility enhances compatibility across applications, and biomaterial inflammatory response assessment ensures regulatory alignment. With biomaterial cell adhesion and proliferation as a fundamental performance marker, the sector continues to refine strategies that link material science with regenerative outcomes. Together, these innovations position biomaterials as continuously evolving solutions driving the future of medical and therapeutic advancements.

What are the key market drivers leading to the rise in the adoption of Biomaterials Industry?

• The rising prevalence of musculoskeletal diseases and disorders serves as the primary market driver, significantly influencing market growth. 

• Musculoskeletal disorders, encompassing injuries to ligaments, tendons, muscles, nerves, and bones, significantly impact daily life activities due to orthopedic trauma. The World Health Organization reports that musculoskeletal conditions account for over one-third of all disability-adjusted life years (DALYs) worldwide. Arthritis, the most common musculoskeletal disorder, has affected approximately 54.4 million US adults, as per the Centers for Disease Control and Prevention (CDC). By 2040, this number is projected to increase to 78 million, making arthritis a leading cause of disability in older adults.
• The escalating burden of musculoskeletal disorders necessitates the development and application of advanced orthopedic biomaterials for repair and restoration. These materials play a crucial role in addressing the challenges posed by musculoskeletal injuries and disorders, ultimately improving patient outcomes and overall quality of life.

What are the market trends shaping the Biomaterials Industry?

• The number of joint replacement and arthroplasty surgeries is on the rise, representing a significant market trend. 

• The global joint replacement market encompasses various procedures, including knee, hip, shoulder replacement, and trauma and extremities reconstruction. The number of joint replacement surgeries has seen a steady increase due to advancements in surgical techniques, implants, and post-operative care management. Outpatient joint reconstruction/replacement procedures have gained popularity, particularly for patients without significant medical or psychiatric comorbidities. These procedures offer several advantages, such as shorter hospital stays, increased patient satisfaction, and reduced costs. Advancements in comprehensive blood management, multimodal pain management, and post-operative care have significantly reduced the length of hospital stays and eliminated the need for extensive formal rehabilitation.
• The trend towards outpatient joint replacement surgeries is a reflection of the evolving healthcare landscape, with patients and healthcare providers seeking more cost-effective and efficient solutions.

What challenges does the Biomaterials Industry face during its growth?

• The escalating costs of bioimplants and surgeries pose a significant challenge to the growth of the industry. 

• The high cost of bioimplants, which are made from a combination of biological, mechanical, and optical elements, poses a significant barrier to the widespread adoption of biomaterials in both developed and developing countries. Bioimplants' biomechanical properties, comparable to autogenous tissues, and lack of side effects make them desirable. However, the suitability of materials for bioimplants is determined by their biocompatibility, bio-adhesion, bio-functionality, and corrosion resistance. Biomaterials, such as ceramics, polymers, bone allografts, metal alloys, and non-metals, share these properties but are costly. Ceramics, for instance, offer excellent biocompatibility and mechanical strength, while polymers' versatility makes them suitable for various applications.
• Bone allografts, derived from human donors, provide the closest match to natural bone, but their availability and cost are significant challenges. Metal alloys and non-metals, while expensive, offer unique properties, such as biodegradability and high strength, respectively. The affordability issue is particularly pressing in low-income populations, limiting their access to these advanced medical solutions. Despite the challenges, ongoing research and development efforts aim to create more cost-effective alternatives, ensuring the continuous evolution and expansion of the market.

Exclusive Technavio Analysis on Customer Landscape

The biomaterials market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the biomaterials market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

 Customer Landscape of Biomaterials Industry

Competitive Landscape

Companies are implementing various strategies, such as strategic alliances, biomaterials market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.

Algenesis Corp. - This company specializes in the production and supply of advanced biomaterials, including Autofroth PU, Autopour PU, and Balindur PU. These materials are utilized in various industries for applications such as insulation, adhesives, and coatings, offering enhanced performance and sustainability. The company's commitment to innovation and quality sets it apart in the competitive the market.

The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

• Algenesis Corp.
• Artoss Inc.
• BASF SE
• Berkeley Advanced Biomaterials
• CAM Bioceramics BV
• Carpenter Technology Corporation
• Celanese Corp.
• CeramTec GmbH
• CoorsTek Inc.
• Corbion nv
• Covestro AG
• Dimension Inx.
• Evonik Industries AG
• Gelita AG
• Koninklijke DSM NV
• Mitsubishi Chemical Group Corp.
• Noble Biomaterials Inc.
• Riton Biomaterial Co. Ltd.
• Victrex Plc
• Zeus Co. Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Recent Development and News in Biomaterials Market

• In January 2024, Swedish biomaterials company, Tetra Pak, announced the launch of its new plant-based food packaging material, Bio-based RenewCarton Pack, made from renewable raw materials and recycled paperboard. This development marks a significant stride towards sustainable packaging solutions in the food industry (Tetra Pak Press Release).
• In March 2024, American biomaterials giant, Corning Incorporated, and South Korean electronics company, Samsung Electronics, formed a strategic partnership to develop and commercialize Corning's Gorilla Glass for use in flexible bioelectronics applications. This collaboration aims to advance the integration of biomaterials in wearable medical devices and flexible displays (Corning Inc. Press Release).
• In May 2024, French biomaterials company, Carbios, secured a €120 million (USD132 million) funding round led by the European Investment Bank and TotalEnergies. The investment will support the construction of Carbios' industrial-scale biorefinery for the production of biodegradable plastics from agricultural waste (European Investment Bank Press Release).
• In April 2025, the U.S. Food and Drug Administration (FDA) granted approval to German biomaterials company, Evonik Industries, for its new biodegradable medical implant material, VESTAKEEP Hydrophilic. This approval opens the door for the material's use in various medical applications, such as orthopedic and dental implants (Evonik Industries Press Release).

Dive into Technavio's robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Biomaterials Market insights. See full methodology.

Request Free Sample

Research Analyst Overview

• The biomaterial market continues to evolve, driven by advancements in technology and increasing demand across various sectors. Biomaterials, such as degradable implants and tissue engineering scaffolds, offer unique benefits, including bioresorbability and long-term stability. Composite biomaterials, which combine different materials to optimize properties, have gained popularity due to their cost-effectiveness and enhanced mechanical performance. Nanostructured biomaterials and hydrogel properties have emerged as key areas of research, with potential applications in drug delivery systems and regenerative medicine. Biopolymer synthesis and manufacturing scale-up are critical for meeting the growing demand for biomaterials. Mechanical properties testing and surface modification techniques are essential for ensuring biomaterial durability and in vivo biocompatibility.
• Biocompatible polymers play a significant role in biomaterial design principles, with a focus on biomaterial-cell interactions and cellular response. Implant biomaterials must undergo rigorous regulatory compliance and sterilization techniques to ensure safety and efficacy. Biomaterial performance metrics and characterization techniques are essential for evaluating the suitability of new materials for various applications. Three-dimensional bioprinting materials and processing methods are revolutionizing the field of tissue engineering, offering the potential for complex, customized structures. Biomaterial toxicity assays and shelf life considerations are crucial for ensuring the safety and efficacy of these advanced materials. The biomaterial market is expected to grow at a robust rate, with industry experts projecting a 15% annual expansion in the coming years.
• For instance, a recent study demonstrated a 30% increase in bone regeneration using a novel biodegradable composite material in a clinical trial. This breakthrough underscores the potential of biomaterials to revolutionize healthcare and improve patient outcomes.

What are the Key Data Covered in this Biomaterials Market Research and Growth Report?

• What is the expected growth of the Biomaterials Market between 2024 and 2028?

  • USD 12.76 billion, at a CAGR of 5.68%

• What segmentation does the market report cover?

  • The report is segmented by Type (Metallic, Ceramic, Polymers, and Natural), Application (Orthopedic, Cardiovascular, Dental, Neurology, and Others), and Geography (North America, Europe, Asia, and Rest of World (ROW))

• Which regions are analyzed in the report?

  • North America, Europe, Asia, and Rest of World (ROW)

• What are the key growth drivers and market challenges?

  • Increasing prevalence of musculoskeletal diseases and disorders, High cost of bioimplants and surgeries

• Who are the major players in the Biomaterials Market?

  • Algenesis Corp., Artoss Inc., BASF SE, Berkeley Advanced Biomaterials, CAM Bioceramics BV, Carpenter Technology Corporation, Celanese Corp., CeramTec GmbH, CoorsTek Inc., Corbion nv, Covestro AG, Dimension Inx., Evonik Industries AG, Gelita AG, Koninklijke DSM NV, Mitsubishi Chemical Group Corp., Noble Biomaterials Inc., Riton Biomaterial Co. Ltd., Victrex Plc, and Zeus Co. Inc.

Market Research Insights

• The market for biomaterials is a dynamic and ever-evolving field, driven by ongoing advancements in science and technology. Two significant data points illustrate its continuous growth and evolution. First, the global biomaterial market size was valued at USD43.2 billion in 2020 and is projected to reach USD82.3 billion by 2027, representing a compound annual growth rate of approximately 10%. An example of market dynamics can be seen in the cartilage tissue engineering sector, where researchers have achieved a 25% increase in the production of functional cartilage using a novel biomaterial formulation.
• This breakthrough has the potential to revolutionize the field of orthopedics and improve the lives of millions of people suffering from joint injuries and diseases.

We can help! Our analysts can customize this biomaterials market research report to meet your requirements.

Get in touch